[go: up one dir, main page]

ATE243698T1 - 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate - Google Patents

1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate

Info

Publication number
ATE243698T1
ATE243698T1 AT00949428T AT00949428T ATE243698T1 AT E243698 T1 ATE243698 T1 AT E243698T1 AT 00949428 T AT00949428 T AT 00949428T AT 00949428 T AT00949428 T AT 00949428T AT E243698 T1 ATE243698 T1 AT E243698T1
Authority
AT
Austria
Prior art keywords
pyrazino
dihydro
oxo
indole derivatives
compounds
Prior art date
Application number
AT00949428T
Other languages
English (en)
Inventor
Ernesto Menta
Francesco Nicotra
Nicoletta Pescalli
Silvano Spinelli
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Application granted granted Critical
Publication of ATE243698T1 publication Critical patent/ATE243698T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00949428T 1999-08-03 2000-07-31 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate ATE243698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001741A IT1313593B1 (it) 1999-08-03 1999-08-03 Derivati di 1,2-diidro-1-oxo-pirazino 1,2-a indolo.
PCT/EP2000/007418 WO2001009136A1 (en) 1999-08-03 2000-07-31 1,2-dihydro-1-oxo-pyrazino[1,2-a]indole derivatives

Publications (1)

Publication Number Publication Date
ATE243698T1 true ATE243698T1 (de) 2003-07-15

Family

ID=11383491

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949428T ATE243698T1 (de) 1999-08-03 2000-07-31 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate

Country Status (8)

Country Link
EP (1) EP1200439B1 (de)
JP (1) JP2003506376A (de)
AT (1) ATE243698T1 (de)
AU (1) AU6278700A (de)
CA (1) CA2393915A1 (de)
DE (1) DE60003560D1 (de)
IT (1) IT1313593B1 (de)
WO (1) WO2001009136A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2254886B1 (de) * 2008-03-28 2016-05-25 Nerviano Medical Sciences S.r.l. 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-on derivate als kinase inhibitoren, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
BR112014022780A8 (pt) 2012-03-16 2021-06-15 Vitae Pharmaceuticals Inc composto modulador de receptor de fígado x, composição farmacêutica que o compreende e seu uso
EP2825541B1 (de) 2012-03-16 2016-06-22 Vitae Pharmaceuticals, Inc. Leber-x-rezeptormodulatoren
UA125334C2 (uk) 2015-06-17 2022-02-23 Пфайзер Інк. Трициклічні сполуки та їх застосування як інгібіторів фосфодіестерази

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648208A1 (de) * 1993-04-05 1995-04-19 Fujisawa Pharmaceutical Co., Ltd. Indol derivate als restosteron 5 alpha-reductase inhibitoren

Also Published As

Publication number Publication date
DE60003560D1 (de) 2003-07-31
CA2393915A1 (en) 2001-02-08
ITMI991741A1 (it) 2001-02-03
EP1200439B1 (de) 2003-06-25
IT1313593B1 (it) 2002-09-09
ITMI991741A0 (it) 1999-08-03
EP1200439A1 (de) 2002-05-02
WO2001009136A1 (en) 2001-02-08
AU6278700A (en) 2001-02-19
JP2003506376A (ja) 2003-02-18

Similar Documents

Publication Publication Date Title
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
YU21401A (sh) Tetrahidropiridoetri
PT998460E (pt) Novos derivados de tetrazole
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DE59909760D1 (de) Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE259813T1 (de) Triazolopyrimidinderivate
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
MXPA03003942A (es) Compuestos bis-heterociclicos con actividad antitumoral y quimiosensibilizante.
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
TR200100133T2 (tr) FKBP İnhibitörleri
ATE269313T1 (de) Tryptase-inhibitoren
PT1244614E (pt) Inibidores de triptase
TR200200017T2 (tr) Benzofuran türevleri
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ES2159489A1 (es) Nuevos derivados de imidazol con actividad antiinflamatoria.
ATE282611T1 (de) Stolonoxide
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties